Open access · US-GOV via ClinicalTrials.gov Clinical trial

Continuous Renal Replacement Therapy With Anticoagulation-free Regimen in Bleeding-risk Patients Using oXiris Membrane - CARROM Study

Authors not listed

National University Hospital, Singapore · 2013

Loss of proteostasis Human Randomized controlled trial

Abstract

The investigators hypothesize that the use of heparin-grafted membrane versus conventional membrane in critically-ill patients with bleeding-risk undergoing continuous renal replacement therapy, will effectively prolong the circuit lifespan, without worsening of the systemic APTT or underlying bleeding risk.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-13 MST

Cite this

APA

Anonymous. (2013). Continuous Renal Replacement Therapy With Anticoagulation-free Regimen in Bleeding-risk Patients Using oXiris Membrane - CARROM Study. <em>National University Hospital, Singapore</em>. https://clinicaltrials.gov/study/NCT01779635

Vancouver

Anonymous. Continuous Renal Replacement Therapy With Anticoagulation-free Regimen in Bleeding-risk Patients Using oXiris Membrane - CARROM Study. National University Hospital, Singapore. 2013.

BibTeX

@misc{anon2013Contin, title = {Continuous Renal Replacement Therapy With Anticoagulation-free Regimen in Bleeding-risk Patients Using oXiris Membrane - CARROM Study}, author = {Anonymous}, journal = {National University Hospital, Singapore}, year = {2013}, }